https://clinicaltrials.gov/ct2/show/NCT02579473?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=09%2F04%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson’s Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214
DESCRIPTION:
Condition: Parkinson’s Disease
Intervention: Drug: SER-214
Sponsor: Serina Therapeutics
Active, not recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT02579473
FIRST POSTED:
Mon, 19 Oct 2015 12:00:00 EDT
LAST UPDATE POSTED:
09/18/19 07:46AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02579473?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=09%2F04%2F2019&lupd_d=14&sort=nwst
